ERBB2 and ovarian carcinoma: However, we basically showed the antitumor efficacy of DARPin-LoPE targeted toxin against human HER2-overexpressing ovarian carcinoma xenograft SKOVip-kat: Even a single-course treatment with the targeted toxin in a dose of 50 μg caused a significant inhibition of the growth of model tumors.